Hypertriglyceridaemia and risk of coronary artery disease

Sugar-sweetened carbonated beverage consumption and coronary artery calcification in asymptomatic men and women

(2016) Sohyun Chun et al.   AMERICAN HEART JOURNAL

A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia

(2016) Björn W. Karlson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Non-HDL Cholesterol and TriglyceridesHighlights

(2016) Rishi Puri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Relationship between serum triglyceride levels and endothelial function in a large community-based study

(2016) Masato Kajikawa et al.   ATHEROSCLEROSIS

The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis

(2016) Nathalie Hennuyer et al.   ATHEROSCLEROSIS

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   ATHEROSCLEROSIS

Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial

(2016) Shun Ishibashi et al.   ATHEROSCLEROSIS

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia

(2016) John J.P. Kastelein et al.   CARDIOLOGY

FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues

(2016) Christian Schlein et al.   Cell Metabolism

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease

(2016) Robert Klempfner et al.  

Volanesorsen. Antisense oligonucleotide targeting ApoC-III, Treatment of familial chylomicronemia syndrome, Treatment of hypertriglyceridemia, Treatment of lipodystrophy

(2016)   DRUGS OF THE FUTURE

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

(2016) Roberto Ferrari et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

Anti-sense oligonucleotide therapies for the treatment of hyperlipidaemia

(2016) Anthony S. Wierzbicki et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Genome-wide association study of serum lipids confirms previously reported associations as well as new associations of common SNPs within PCSK7 gene with triglyceride

(2016) Makoto Kurano et al.   JOURNAL OF HUMAN GENETICS

Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results

(2016) Xiaohong Yang et al.   JOURNAL OF LIPID RESEARCH

Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study

(2016) Xiaona Wang et al.   Lipids in Health and Disease

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease

(2016) Frederick E. Dewey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight loss and improvement of lipid profiles in morbidly obese patients after laparoscopic one-anastomosis gastric bypass: 2-year follow-up

(2016) Miguel A. Carbajo et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease

(2016) Robert Klempfner et al.   Circulation-Cardiovascular Quality and Outcomes

Triglyceride-Rich Lipoproteins and Coronary Artery Disease Risk: New Insights From Human Genetics

(2015) S. A. Khetarpal et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology

(2015) Guy De Backer et al.   ATHEROSCLEROSIS

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy

(2015) Carlos Aguiar et al.   ATHEROSCLEROSIS SUPPLEMENTS

Serum Triglyceride Levels and Cardiovascular Disease Events in Koreans

(2015) Eun Hee Kim et al.   CARDIOLOGY

Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease?

(2015) Željko Reiner   CARDIOLOGY

Adverse Effects of Statins - Myths and Reality

(2015) Iveta Simic et al.   CURRENT PHARMACEUTICAL DESIGN

Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion

(2015) Yan Wang et al.   JOURNAL OF LIPID RESEARCH

Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins

(2015) Gregory G. Schwartz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome

(2015) Charles Daniel Meyers et al.   Lipids in Health and Disease

Dysfunctional HDL and atherosclerotic cardiovascular disease

(2015) Robert S. Rosenson et al.   Nature Reviews Cardiology

Management of patients with familial hypercholesterolaemia

(2015) Željko Reiner   Nature Reviews Cardiology

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

(2015) Daniel Gaudet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apolipoprotein C-III: From Pathophysiology to Pharmacology

(2015) Giuseppe Danilo Norata et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Icosapent Ethyl for Treatment of Elevated Triglyceride Levels

(2014) Scott D. Nelson et al.   ANNALS OF PHARMACOTHERAPY

Differential Association of Plasma Angiopoietin-Like Proteins 3 and 4 With Lipid and Metabolic Traits

(2014) Nidhi Mehta et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)

(2014) Hiroyasu Iso et al.   ATHEROSCLEROSIS

Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor

(2014) Alexander Tenenbaum et al.   Cardiovascular Diabetology

Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor–Dependent and –Independent Mechanisms

(2014) Shirya Rashid et al.   CIRCULATION

Postprandial hypertriglyceridemia as a coronary risk factor

(2014) Jan Borén et al.   CLINICA CHIMICA ACTA

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study

(2014) M. Thomsen et al.   CLINICAL CHEMISTRY

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

(2014) K. K. Ray et al.   EUROPEAN HEART JOURNAL

Mendelian randomization of blood lipids for coronary heart disease

(2014) Michael V. Holmes et al.   EUROPEAN HEART JOURNAL

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

(2014) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

(2014) Robert S. Rosenson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway

(2014) Grace M Egeland et al.   European Journal of Preventive Cardiology

Induction of ATF3 Gene Network by Triglyceride-Rich Lipoprotein Lipolysis Products Increases Vascular Apoptosis and Inflammation

(2013) Hnin H. Aung et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: Findings from the EUROASPIRE III survey

(2013) Željko Reiner et al.   ATHEROSCLEROSIS

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2013) David C. Goff et al.   CIRCULATION

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

(2013) Frank M. Sacks et al.   CIRCULATION

Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans

(2013) Mark J. Graham et al.   CIRCULATION RESEARCH

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report

(2013) Scott M. Grundy et al.   Journal of Clinical Lipidology

Common variants associated with plasma triglycerides and risk for coronary artery disease

(2013) Ron Do et al.   NATURE GENETICS

Statins in the primary prevention of cardiovascular disease

(2013) Željko Reiner   Nature Reviews Cardiology

Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update

(2013) Ž. Reiner   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Triglyceride-Rich Lipoprotein Modulates Endothelial Vascular Cell Adhesion Molecule (VCAM)-1 Expression via Differential Regulation of Endoplasmic Reticulum Stress

(2013) Ying I. Wang et al.   PLoS One

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

(2013) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed

(2012) Elena Makoveichuk et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Sweetened Beverage Consumption, Incident Coronary Heart Disease, and Biomarkers of Risk in Men

(2012) Lawrence de Koning et al.   CIRCULATION

Omega 3 Fatty Acids and Cardiovascular Outcomes

(2012) Sradha Kotwal et al.  

Gene therapy for lipoprotein lipase deficiency

(2012) Daniel Gaudet et al.   CURRENT OPINION IN LIPIDOLOGY

Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: A 15-year follow-up of the Chinese Multi-provincial Cohort Study

(2012) Jing Liu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Trends in Lipids and Lipoproteins in US Adults, 1988-2010

(2012) Margaret D. Carroll et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia

(2012) R. P. Surendran et al.   JOURNAL OF INTERNAL MEDICINE

Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality

(2012) Ian Graham et al.   Current Cardiology Reports

An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia

(2011) Christopher T. Johansen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Vascular Disease Risk in Patients With Hypertriglyceridemia: Endothelial Progenitor Cells, Oxidative Stress, Accelerated Senescence, and Impaired Vascular Repair

(2011) Eric Thorin   CANADIAN JOURNAL OF CARDIOLOGY

Triglycerides and Cardiovascular Disease

(2011) Michael Miller et al.   CIRCULATION

The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses

(2011) H. N. Ginsberg   DIABETES CARE

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II)

(2011) L Vanhees et al.   European Journal of Preventive Cardiology

Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control

(2010) Vincent J. Carey et al.   AMERICAN JOURNAL OF CARDIOLOGY

Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey

(2010) Željko Reiner et al.   ATHEROSCLEROSIS

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

(2010)   LANCET

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

(2010) Min Jun et al.   LANCET

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

(2010) Christopher T Johansen et al.   NATURE GENETICS

Combination Lipid Therapy in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Public perceptions of cardiovascular risk factors in Croatia: The PERCRO survey

(2010) Željko Reiner et al.   PREVENTIVE MEDICINE

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

(2009) Ole Faergeman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Lipoprotein lipase: from gene to obesity

(2009) Hong Wang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Combined therapy in the treatment of dyslipidemia

(2009) Željko Reiner   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

(2009) Kimber L. Stanhope et al.   JOURNAL OF CLINICAL INVESTIGATION

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

(2008) Jean-Charles Fruchart et al.   AMERICAN JOURNAL OF CARDIOLOGY

Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup

(2008) Kimber L Stanhope et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

(2008) Jean-Charles Fruchart et al.   Diabetes & Vascular Disease Research

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

(2008) Anne Hiukka et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

(2008) Michael Miller et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Relative Safety of Gemfibrozil and Fenofibrate in the Absence of Concomitant Cerivastatin Use

(2007) Noa Holoshitz et al.   AMERICAN JOURNAL OF CARDIOLOGY